These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33486934)

  • 21. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Significance of Lymph Node Ratio and Total Lymph Nodes Examined in Determining the Indications of Adjuvant Radiation in pN2 Non-small Cell Lung Cancer.
    Zhu F; Wang H; Ashamalla H
    Clin Lung Cancer; 2022 Sep; 23(6):e384-e393. PubMed ID: 35676168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.
    Deng W; Xu T; Wang Y; Xu Y; Yang P; Gomez D; Liao Z
    Lung Cancer; 2018 Aug; 122():60-66. PubMed ID: 30032846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio precisely predicts the benefit of postoperative radiotherapy in esophageal cancer: A retrospective cohort study.
    Liang Y; Jian Q; Deng MG; Yi Z; Peng C; Lu C; Yang H; Liu J
    Asian J Surg; 2023 Sep; 46(9):3680-3686. PubMed ID: 37059676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer.
    Hong SA; Son MW; Cho J; Lee CH; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee KT; Lee MS
    Medicine (Baltimore); 2018 Jan; 97(3):e9703. PubMed ID: 29505025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Lymph Node Ratio Association With Long-term Patient Survival After Surgery for Node-Positive Merkel Cell Carcinoma.
    Cheraghlou S; Agogo GO; Girardi M
    JAMA Dermatol; 2019 Jul; 155(7):803-811. PubMed ID: 30825411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of lymph node ratio on survival in non-small-cell lung cancer.
    Sezen CB; Kalafat CE; Doğru MV; Aker C; Erdogu V; Saydam O; Metin M
    Acta Chir Belg; 2023 Feb; 123(1):36-42. PubMed ID: 34006183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of positive nodal chain ratio on individualized multimodality therapy in non-small-cell lung cancer.
    Cao Q; Zhang B; Zhao L; Wang C; Gong L; Wang J; Pang Q; Li K; Liu W; Li X; Wang P; Wang P
    Tumour Biol; 2015 Jun; 36(6):4617-25. PubMed ID: 25623115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
    [No Abstract]   [Full Text] [Related]  

  • 34. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
    Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
    J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
    Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
    Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].
    Zhang S; Wang L; Lu F; Pei Y; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 Nov; 22(11):702-708. PubMed ID: 31771739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
    Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
    Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 40. The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.
    Xu XL; Zheng WH; Zhu SM; Zhao A; Mao WM
    PLoS One; 2015; 10(7):e0133076. PubMed ID: 26177369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.